Semaglutide Semaglutide (Ozempic / Wegovy / Rybelsus / 胰妥讚)
4
conditions reviewed
A
top tier
A 🔵 A Moderate Evidence
Type 2 Diabetes
第二型糖尿病
Published 🚨 高市場風險
→
A 🔵 A Moderate Evidence Cardiovascular Disease
心血管疾病 (CVD)
Published with Warning 🚨 高市場風險
→
A 🔵 A Moderate Evidence Masld
脂肪肝 MASLD/MASH
Published with Warning 🚨 高市場風險
→
A 🔵 A Moderate Evidence Obesity
肥胖 (BMI ≥30)
Published with Warning 🚨 高市場風險
→